Line 76: | Line 76: | ||
<div class="row"> | <div class="row"> | ||
<h1 class="title">Experiments</h1> | <h1 class="title">Experiments</h1> | ||
− | <h1><span>Our long-term goal is to improve the health-promoting effects of ginsenosides. We believe that sterols in the ginsenosides are responsible for their main benefits. <br> Therefore in the past projects we engineered synthetic squalene cyclase for in situ production of | + | <h1><span>Our long-term goal is to improve the health-promoting effects of ginsenosides. We believe that sterols in the ginsenosides are responsible for their main benefits. <br> Therefore in the past projects we engineered synthetic squalene cyclase for in situ production of ginseng-sterols in human cells and produced synthetic β-glucosidase in E.coli for removal of sugar from ginsenosides.<br> In the current strategy, in the wake of “No release” policy of the iGEM community, we are able to by-pass synthetic biology methods to achieve our goal by applying in vitro chemical reactions. </span></h1> |
<a href="https://static.igem.org/mediawiki/2018/a/a5/T--UST_Beijing--ep.pdf" class="btn btn-info btn-large btn-rounded">CLICK FOR PDF</a> </div> | <a href="https://static.igem.org/mediawiki/2018/a/a5/T--UST_Beijing--ep.pdf" class="btn btn-info btn-large btn-rounded">CLICK FOR PDF</a> </div> | ||
</div> | </div> | ||
Line 88: | Line 88: | ||
<blockquote> | <blockquote> | ||
<p>Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herb catalogs: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. | <p>Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herb catalogs: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. | ||
− | Current herb preparation and administration practice results in poor absorption profile | + | Current herb preparation and administration practice results in poor absorption profile limit its efficacy and cost-effectiveness. |
Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical. | Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical. | ||
</p> | </p> | ||
Line 99: | Line 99: | ||
<div class="span4"><blockquote><p>A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry</p></blockquote></div> | <div class="span4"><blockquote><p>A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry</p></blockquote></div> | ||
<div class="span4" ><img src="https://static.igem.org/mediawiki/2018/3/32/T--UST_Beijing--ep14.png" heigth="70%" alt=""></div> | <div class="span4" ><img src="https://static.igem.org/mediawiki/2018/3/32/T--UST_Beijing--ep14.png" heigth="70%" alt=""></div> | ||
− | <h2 class="title">1. Thin—layer chromatography | + | <h2 class="title">1. Thin—layer chromatography</h2> |
<h3>Experimental purpose: Through contrast experiments of different method, find out the optimum condition of developing agent ratio in TLC system | <h3>Experimental purpose: Through contrast experiments of different method, find out the optimum condition of developing agent ratio in TLC system | ||
<br>Standarded sample: Rb1, Re1, Rg1 10mg/ml<br>After many preliminary experiments, we try to find out a general range of proportion. Here is the last TLC experiment.</h3> | <br>Standarded sample: Rb1, Re1, Rg1 10mg/ml<br>After many preliminary experiments, we try to find out a general range of proportion. Here is the last TLC experiment.</h3> |
Revision as of 20:49, 9 October 2018
Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herb catalogs: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. Current herb preparation and administration practice results in poor absorption profile limit its efficacy and cost-effectiveness. Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical.
In the past, two approaches have been tried to achieve this: (1) Synthesize ginseno-sterols in situ Pro: no need to plant ginseng and harvest, continuous supply of ginseno-sterols; Con: interference with physiology, lack of control in production. (2) Produce beta-glucosides in the gut micro-organism. Pro: convenient to hydrolyze ginsenosides in the gut; Con: interference with gut physiology and probiotics.
In the current third approach, we use chemical reaction to hydrolyze the conjugated sugars, to satisfy “No-release” policy if iGEM safety requirement.
A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry